| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(92)90867-3 |
| P698 | PubMed publication ID | 1347095 |
| P2093 | author name string | M Terada | |
| S Kawasaki | |||
| M Makuuchi | |||
| H Kawarazaki | |||
| H Matsunami | |||
| S Ishizone | |||
| P433 | issue | 8793 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 580-581 | |
| P577 | publication date | 1992-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Liver regeneration in recipients and donors after transplantation | |
| P478 | volume | 339 |
| Q90575321 | A novel form of Deleted in breast cancer 1 (DBC1) lacking the N-terminal domain does not bind SIRT1 and is dynamically regulated in vivo |
| Q79761956 | Acceleration of hepatobiliary dynamics in liver transplant donors |
| Q40622967 | Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats |
| Q38508711 | Adult living donor liver transplantation using the right lobe |
| Q33890380 | Animal models of acute hepatic failure |
| Q37562920 | Chances and risks in living donor liver transplantation |
| Q73219625 | Changes in graft volume after living-related liver transplantation |
| Q73316125 | Changes in liver regenerative factors in a case of living-related liver transplantation |
| Q44954926 | Clinical significance of gastrointestinal bleeding after living donor liver transplantation |
| Q36339420 | Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation. |
| Q51503864 | Complications in 100 living-liver donors. |
| Q84459221 | Convergence process of volumetric liver regeneration after living-donor hepatectomy |
| Q53536071 | Correlation of portal venous velocity and portal venous flow with short-term graft regeneration in recipients of living donor liver transplants. |
| Q36783322 | Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients |
| Q83532613 | Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation |
| Q38521062 | Donor safety in living donor liver transplantation using the right lobe |
| Q73983902 | Donor selection for living-related liver transplantation |
| Q53618517 | Effects of Kupffer cell inactivation on graft survival and liver regeneration after partial liver transplantation in rats. |
| Q44591453 | Effects of middle hepatic vein reconstruction on right liver graft regeneration |
| Q47421573 | Estimation of liver size for liver transplantation: the impact of age and gender |
| Q47339441 | Extension of the indication for living related liver transplantation from children to adults based on resolution of graft size mismatch in relation to tissue oxygenation and metabolic load: a case report |
| Q36545066 | Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients. |
| Q73304714 | Family perspectives of the factors facilitating Taiwanese pediatric recipients' recovery from liver transplantation: one year follow-up |
| Q73012795 | Fatty livers require larger graft volume for successful liver transplantation than normal livers: an experimental study |
| Q46664890 | Functional analysis of grafts from living donors. Implications for the treatment of older recipients. |
| Q78575253 | Gastrointestinal bleeding after living-related liver transplantation |
| Q80256756 | Gene expression profiles in living donors immediately after partial hepatectomy - the initial response of liver regeneration |
| Q47340803 | Graft size-matching in living related partial liver transplantation in relation to tissue oxygenation and metabolic capacity |
| Q64080581 | Graft-to-Recipient Weight Ratio Associated With Tacrolimus Metabolism Following Pediatric Living Donor Liver Transplantations |
| Q52876493 | Growth hormone/insulin-like growth factor 1 dynamics in adult living donor liver transplantation. |
| Q43816709 | Hepatectomy and liver regeneration: from experimental research to clinical application |
| Q47447028 | Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation |
| Q91981419 | Human Liver Regeneration: An Etiology Dependent Process |
| Q51744648 | Impact of Portal Hemodynamic Changes in Partial Liver Grafts on Short-Term Graft Regeneration in Living Donor Liver Transplantation. |
| Q80223421 | Impact of live donor age (>or=50) on liver transplantation |
| Q50636042 | Is acute rejection deleterious to long-term liver allograft function? |
| Q37577610 | Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? |
| Q53487044 | Ligation of left renal vein as a salvage procedure for splenorenal shunt after living donor liver transplantation: a case report. |
| Q34275161 | Live donor liver transplantation |
| Q61968944 | Liver and spleen change in the living related liver donation |
| Q77345070 | Liver regeneration after partial hepatectomy is non-uniform: flow cytometric bromodeoxyuridine incorporation and cell cycle studies in a porcine model |
| Q74571263 | Liver regeneration following skin transplantation in the rat: a morphometric and immunohistochemical study |
| Q43929239 | Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients |
| Q35543605 | Living donor liver transplantation and hepatitis C. |
| Q50453451 | Living donor liver transplantation using a graft with periportal fibrosis |
| Q36063324 | Living donor liver transplantation: issues regarding left liver grafts |
| Q44886384 | Living donor liver transplantation: summary of a conference at The National Institutes of Health |
| Q51400855 | Living liver donor surgery: report of initial anesthesia experience. |
| Q74263176 | Living related liver transplantation in adults |
| Q73304724 | Living-related liver transplantation in adults compared with children |
| Q74571054 | Living-related partial liver transplantation in pediatric patients |
| Q46351303 | Long-term follow-up of living liver donors |
| Q35082442 | Loss of pediatric kidney grafts during the "high-risk age window": insights from pediatric liver and simultaneous liver-kidney recipients |
| Q48628533 | Lung alveoli: endogenous programmed destruction and regeneration |
| Q57724711 | Oxidative stress and signaling in the liver |
| Q84382759 | Partial liver transplantation |
| Q36916904 | Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation |
| Q37157896 | Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients |
| Q45729578 | Platelet count reduction and outcomes in living liver donors |
| Q28512092 | Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice |
| Q37790160 | Potential applications for cell regulatory factors in liver progenitor cell therapy |
| Q72567604 | Preoperative measurement of segmental liver volume of donors for living related liver transplantation |
| Q43859533 | Safe donor hepatectomy for living related liver transplantation |
| Q73669103 | Significance of portal venous flow in graft regeneration after living related liver transplantation |
| Q77925631 | Sonographic measurement of the volume of the left lateral segment of the liver |
| Q35549874 | Split-Liver Transplantation: A Review |
| Q53259862 | Standard formula for liver volume in Middle Eastern Arabic adults. |
| Q73304615 | Standard liver volume in adults |
| Q52205356 | Standard liver volume in the Caucasian population. |
| Q44466953 | Successful transplantation of a 20% partial liver graft in rats: a technical innovation |
| Q27346408 | Suppression of graft regeneration, not ischemia/reperfusion injury, is the primary cause of small-for-size syndrome after partial liver transplantation in mice |
| Q77632329 | Technique of triple split-liver transplantation in pigs using inferior vena cava reconstruction and intraoperative intrahepatic portosystemic shunt |
| Q42049096 | Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration |
| Q73794903 | Volume measurement by computed tomography in auxiliary heterotopic partial liver transplant recipients: follow-up results |
| Q34892632 | Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy |
| Q53314691 | [Computerized liver volume for evaluation and following liver regeneration after partial hepatectomy in swines]. |
| Q79268958 | [Living donor liver transplantation] |
Search more.